SEC Form 4 · accession 0001683168-18-000018
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
Dec 29, 2017
Accepted (ET)
Jan 2, 2018 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.60 | Dec 29, 2017 | A | 10,350 | A | — | Dec 29, 2027 | Common Stock | 10,350 | 10,350 | D |
Explanation of responses
- F1Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant: Q4 2017.